Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2021-12-22 Board/Management Inform…
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 100% confidence The document lists the names and roles of the board of directors and board committees of Guangdong Tannery Limited, effective from a specific date. It does not contain financial data, audit results, or meeting minutes, but rather announces the composition and structure of the board and its committees. This fits the definition of Board/Management Information (MANG), which covers announcements of changes or details about the company's board of directors or senior management.
2021-12-22 English
CHANGES OF NON-EXECUTIVE DIRECTORS
Board/Management Information Classification · 100% confidence The document is an announcement from Guangdong Tannery Limited regarding changes in its board of directors, specifically the resignation of two Non-Executive Directors and the appointment of a new Non-Executive Director. It includes personal particulars of the new appointee and details about the terms of appointment. There is no financial data, earnings information, or report publication mentioned. The content clearly fits the category of announcements about changes in the company's board or senior management. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (5485 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2021-12-22 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 95% confidence The document is a list of directors and their roles and functions for Guangdong Tannery Limited, effective from a specific date. It details the composition of the Board of Directors and Board Committees, including Executive, Non-Executive, and Independent Non-Executive Directors, as well as committee memberships. There is no financial data, no mention of financial results, no voting results, no legal proceedings, no capital changes, and no report publication. The content is clearly about board and management information, specifically announcing the board structure and roles. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused solely on board composition, supporting this classification with high confidence.
2021-12-15 English
APPOINTMENT OF CHAIRMAN AND EXECUTIVE DIRECTOR, RE-DESIGNATION OF DIRECTOR, CHANGE OF CHAIRMAN OF NOMINATION COMMITTEE AND CHANGE OF AUTHORISED REPRESENTATIVE
Board/Management Information Classification · 100% confidence The document is an announcement from Guangdong Tannery Limited regarding changes in the company's board of directors and senior management positions, including appointment of a new chairman and executive director, re-designation of a director, and changes in committee chairmanship and authorized representative. It includes detailed personal particulars of the directors involved, their roles, and related disclosures as required by the Hong Kong Stock Exchange Listing Rules. There is no financial data, earnings information, or report publication mentioned. The content clearly fits the category of Board/Management Information (MANG) as it announces changes in the company's board and senior management.
2021-12-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 November 2021. It details movements in issued shares, share options, warrants, convertibles, and other share-related information. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share movements. It is not a financial report, earnings release, or management discussion. It is a regulatory filing related to shareholding and capital movements but does not fit into categories like Major Shareholding Notification (MRQ) or Share Issue/Capital Change (SHA) because it reports monthly returns on share movements as required by listing rules. The document length is 3752 characters, which is relatively short and typical for regulatory filings. Therefore, the best classification is Regulatory Filings (RNS), as it is a general regulatory announcement and does not fit more specific categories.
2021-12-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021
Share Issue/Capital Change Classification · 95% confidence The document is a monthly return for equity issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules, specifically detailing movements in securities for the month ended 31 October 2021. It includes information on movements in issued shares, share options, warrants, convertibles, and other agreements related to share issuance. The document is submitted to the Hong Kong Exchanges and Clearing Limited and is a regulatory filing related to share capital and securities movements. It is not a full financial report, earnings release, or management discussion, but rather a regulatory compliance document reporting share capital movements. Given the content and purpose, this fits best under the category of Share Issue/Capital Change (SHA). The document length is under 5,000 characters, but it contains substantive data on share movements, not just an announcement of a report, so it is not an RPA or RNS. Therefore, the classification is SHA with high confidence.
2021-11-01 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.